Studies in health technology and informatics · 2026
Unlexi: Developing a Prototype of a Digital Emotion-Focused Therapy Tool for Alexithymia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tsubaki Kanako, Abidi Samina
Аннотация
BACKGROUND: Alexithymia-difficulty identifying and expressing emotions-is positively correlated with multiple psychiatric disorders and complicates psychotherapy, yet remains under-addressed.
OBJECTIVE: To develop a prototype for a clinician-linked digital Emotion-Focused Therapy (EFT) called Unlexi, a homework-style model.
METHODS: We developed the prototype with eligibility excluding acute states and requiring TAS-20 ≥ 51 with Readiness for Therapy Questionnaire screening. In the prototype, 12 weekly EFT modules are delivered with brief felt-sense pauses and a safety "Pause" triggering. NLP analyzes free text/voice to generate immediate sentiment feedback for users and clinicians.
RESULTS: The prototype comprises 129 screens (23 for clinicians, 110 for patients).
CONCLUSIONS: Validated by the originator of EFT for clinical fidelity, Unlexi is now moving toward app development and subsequent feasibility testing.
OBJECTIVE: To develop a prototype for a clinician-linked digital Emotion-Focused Therapy (EFT) called Unlexi, a homework-style model.
METHODS: We developed the prototype with eligibility excluding acute states and requiring TAS-20 ≥ 51 with Readiness for Therapy Questionnaire screening. In the prototype, 12 weekly EFT modules are delivered with brief felt-sense pauses and a safety "Pause" triggering. NLP analyzes free text/voice to generate immediate sentiment feedback for users and clinicians.
RESULTS: The prototype comprises 129 screens (23 for clinicians, 110 for patients).
CONCLUSIONS: Validated by the originator of EFT for clinical fidelity, Unlexi is now moving toward app development and subsequent feasibility testing.